SURROZEN INC
Summary
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 154 M
Avg. Deal Size£ 154 M
All rights reserved. Copyright © 2025 Datasite
